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Abstract
Molecular epidemiological investigation of measles outbreaks can document the interruption of
endemic measles transmission and is useful for establishing and clarifying epidemiological links
between cases in geographically distinct clusters. To determine the distribution of measles virus
genotypes in the prevaccine and postvaccine eras, a literature search of biomedical databases,
measles surveillance websites and other electronic sources was conducted for English language
reports of measles outbreaks or genetic characterization of measles virus isolates. Genotype
assignments based on classification systems other than the currently accepted WHO nomenclature
were reassigned using the current criteria. This review gives a comprehensive overview of the
distribution of MV genotypes in the prevaccine and postvaccine eras and describes the
geographically diverse distribution of some measles virus genotypes and the localized distributions
of other genotypes.
Introduction
Although measles virus (MV) is serologically monotypic,
the genetic characterization of wild-type viruses has iden-
tified eight clades (A – H), which have been divided into
22 genotypes and one proposed genotype. Clades B, C, D,
G and H each contain multiple genotypes (B1 – 3, C1 – 2,
D1 – 10, G1 – 3, H1 – 2) while clades A, E and F each con-
tain a single genotype (A, E, F) [1,2]. The sequences of the
vaccine strains indicate that the wild type viruses from
which they were derived were all members of genotype A.
All measles genotypes can be neutralized by serum from
vaccinated persons in vitro, although with varying effi-
ciency [3,4]. There are no known biological differences
between viruses of different genotypes. Specific measles
genotypes are not associated with differences in severity of
disease, likelihood of developing severe sequela such as
subacute sclerosing panencephalitis or inclusion body
encephalitis, or variability in sensitivity of laboratory
diagnosis.
Analysis of the variability in the nucleotide sequences of
wild-type MVs has enabled the use of molecular epidemi-
ologic techniques for measles surveillance. The molecular
data, when used in conjunction with standard case report-
ing and investigation, can help to identify epidemiologi-
cal links between geographically distinct cases and
outbreaks as well as track importations of MV. [5-7]. Also,
approximately 5% of vaccine recipients experience mild
symptoms (rash and fever) after vaccination and these
cases could be misclassified as wild-type measles [8].
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Genetic characterization of viral isolates or RT-PCR prod-
ucts is the only laboratory test that can differentiate
between vaccine-associated cases and wild-type infection
[6,9,10].
In 1998, the World Health Organization (WHO) recom-
mended a standard protocol for the designation of mea-
sles genotypes. These recommendations, updated in 2001
and 2003, also included a standard analysis protocol and
designation of standard reference strains (see Additional
file 2) against which all newly characterized isolates
should be compared [2,11,12]. The minimum amount of
sequence data required to assign a virus to a genotype are
the 450 nucleotides encoding the carboxy terminus of the
N protein. The entire sequence of the coding region of the
H gene should be obtained from representative isolates
[11]. New genotypes are designated if the nucleotide
sequence differs from the closest reference sequence by
more than 2.5% in N and 2.0% in H [2]. Additionally,
phylogenetic analysis should produce similar tree topog-
raphies using at least two different analysis methods. Sev-
eral isolates or clinical specimens should be sequenced
and at least one viral isolate should be available as the ref-
erence strain. Finally, new genotype classifications should
be useful for epidemiological studies, by providing a
means to identify the source or transmission pathway of
infection and by contributing to our understanding of the
global distribution of MV genotypes [2].
The purpose of this summary is to collate all available
reports of MV genotypes and to standardize the published
genotype nomenclature, according to the current WHO
criteria, with the aim of giving a comprehensive overview
of the distribution of MV genotypes in the prevaccine and
postvaccine eras.
Methods
An examination of the National Library of Medicine
"PubMed" [13] search engine using the keyword "mea-
sles" combined with "genotypes" and "sequence" was per-
formed to identify English language publications or
abstracts describing measles genotyping.
Additional sources included the reference lists of articles
identified by "PubMed" and electronic sources such as the
CDC and PAHO measles network Internet pages and the
NCBI Genbank website [14-16]. Measles outbreak alerts
were received through the WHO network, which distrib-
utes outbreak notifications. In addition, subscription
based electronic newsletters such as ProMED mail [17]
and Immunization newsbrief [18] were scrutinized for
information relating to measles outbreaks. Direct contact
was made with the notifying laboratory or health unit
requesting genotype information if available.
A table produced by participants at the 1998 WHO meet-
ing listed older classification systems and the comparable
genotype classifications under the universally accepted
system. This table was used to reclassify genotypes cited in
publications prior to 1998 [11]. In some cases, later pub-
lications from the same or other groups were used to
assign current genotypes to viruses classified before 1998.
Results and Discussion
One hundred and twenty eight studies were identified
through the PubMed search, 67 of which described the
genotype of MV isolates. Four internet websites were iden-
tified (including Genbank) and a further 27 articles were
identified from the reference lists of cited publications or
from outbreak notification lists such as ProMED [17] and
Immunization Newsbrief [18].
Temporal distribution of measles virus genotypes 1951 –  2004 Figure 1
Temporal distribution of measles virus genotypes 1951 – 
2004. Summary of distribution of MV genotypes from the 
prevaccine era to 2004. Refer to Additional file 1 for com-
plete referencing of data shown in figure. Data reflects publica-
tions available as of August 2005.Virology Journal 2005, 2:87 http://www.virologyj.com/content/2/1/87
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Table 1: Distribution of MV genotypes by WHO geographical region 1950s – 2004. Countries in which MV virus has been detected. No 
distinction has been made between endemic transmission or instances of MV importation. (data reflects publications available as of 
August 2005). Refer to Additional file 1 for details of endemic transmission and imported measles cases and for complete referencing 
of data.
Geno-type AFRO1 EMRO2 SEARO3 WPRO4 Europe5 Americas6
A China, Japan Romania, UK 
Finland, Russia, 
Czech Republic, 
Slovakia
Brazil, USA, 
Argentina,
B1 Cameroon
B2 Gabon South 
Africa, Angola
B3 Gambia, Nigeria, 
Kenya, Ghana, 
Algeria, 
Cameroon, Rep. 
of Congo, Dem. 
Rep. of Congo 
Burkina Faso, 
Equatorial Guinea
Sudan, Tunisia, 
Libya
France, Spain 
Germany, UK,
USA
C1 Japan Nth Ireland, Spain, 
Germany
USA, Canada, 
Argentina
C2 Zimbabwe Morocco Australia Austria, France, 
Belgium, 
Netherlands, 
Czech Republic, 
Slovakia, Spain, 
Italy, Germany, 
UK, Luxembourg, 
Denmark,
USA, Brazil, 
Canada,
D1 Australia UK, Nth Ireland
D2 South Africa, 
Zambia
Ireland, UK, Spain USA
D3 South Africa Micronesia, 
Philippines, PNG, 
Japan, Australia, 
Taiwan
UK, Denmark USA, Canada
D4 South Africa, 
Namibia, Kenya, 
Ethiopia
Pakistan, Lebanon, 
Afghanistan, Syria, 
Iran
India, Nepal Japan, Australia UK, Denmark, 
Netherlands, 
Germany, Spain, 
Croatia, Russia,
USA, Canada
D5 Namibia Thailand, 
Bangladesh
Japan, Malaysia, 
Micronesia, 
Australia, New 
Zealand, 
Cambodia, Guam, 
Rep. of Korea
UK, Germany South America, 
USA, Canada, 
Brazil
D6 UK, Ireland, Spain, 
Germany, Austria, 
Italy, Greece, 
Croatia, Turkey, 
Ukraine, Poland, 
Russia, 
Luxembourg, 
Bosnia, Israel, 
Norway, 
Denmark, 
Netherlands
USA, Canada, 
Brazil, Bolivia, 
Argentina, 
Uruguay, 
Dominican 
Republic \Haiti
D7 Sri Lanka, 
Myanmar (Burma), 
India
Australia UK, Germany, 
Sweden, Europe, 
France, Spain, Italy
El Salvador, USA, 
Canada, MexicoVirology Journal 2005, 2:87 http://www.virologyj.com/content/2/1/87
Page 4 of 9
(page number not for citation purposes)
Figure 1 and Table 1 summarize the temporal and geo-
graphical distribution of MV genotypes from the early
1950s to 2004 but do not differentiate between cases of
endemic or imported measles virus. Genotype and loca-
tion specific references are not cited in the following
results section but can be found in the relevant genotype
specific section in the comprehensive table which accom-
panies this paper (see Additional file 1, also available
from the website of the WHO Western Pacific Regional
Reference Laboratory for measles, The Victorian Infectious
Diseases Reference Laboratory, Melbourne, Australia
http://www.vidrl.org.au/labsandunits/measles/
meas_genotyping.htm).
Routine molecular characterization of wild-type measles
viruses was initiated in response to a global resurgence of
measles disease in the late 1980s and the concurrent avail-
ability of sensitive techniques (e.g. RT-PCR and auto-
mated sequencing) for the investigation of viral genomes.
Prior to that date, only a few isolates of measles were avail-
able for molecular characterization and reliable epidemi-
ologic information was not available for many of these
isolates. In the era before the widespread use of measles
vaccine, genotypes A, C1, and D1 were detected. Geno-
type A virus includes the prototype Edmonston strain, the
progenitor for most of the current measles vaccines. Anal-
ysis of MV sequences obtained from SSPE cases, resulting
from initial infections that occurred during the 1950s and
1960s, detected genotypes C1, D1, E and F, providing fur-
ther evidence that genotype A was not the only genotype
detected during the prevaccine era [19-24]. However, data
from these earlier studies must be interpreted cautiously
due to the large number of mutations in SSPE sequences
and the lack of standardization. Of course, detection of
various genotypes in SSPE cases reflects efforts to study
this devastating illness and should not be taken as an indi-
cation that one genotype is more likely to cause SSPE than
another [25]. Retrospective sequence analysis of viral iso-
lates collected during the 1970s showed continued detec-
tion of genotypes C1 and D1 and the first detections of
genotypes C2, D2, D4, E and F.
As virologic surveillance expanded in the late 1980s and
1990s, the number of genotypes detected in cases and out-
breaks increased substantially to include the 23 genotypes
now recognized by the WHO. However, some genotypes
(B1, D1, E, F, G1) have not been detected in the last 15
years and are considered inactive.
D8 Ethiopia Pakistan, Oman, India, Bangladesh, 
Nepal
Australia UK, Spain, 
Yugoslavia, 
Albania, Italy, 
Lithuania
USA, Canada
D9 Indonesia Australia, Japan Europe Venezuela, 
Colombia
D10 Uganda
E Germany, 
Denmark
USA, Canada
F Spain
G1 USA
G2 South Africa Indonesia Australia, Malaysia Netherlands, UK, 
Germany
Mexico, USA
G3 E. Timor, 
Indonesia
Australia
H1 Thailand Australia, China, 
New Zealand, 
Mongolia, 
Singapore, Japan, 
Rep. of Korea, 
Rep. of Marshall 
Islands
UK, Spain, 
Netherlands, 
Denmark, 
Germany
USA, Canada, 
Chile, Mexico
H2 China, Vietnam, 
Australia
USA
1AFRO – WHO African region, 2EMRO – WHO Eastern Mediterranean region, 3SEARO – WHO South East Asian region, 4WPRO – WHO 
Western Pacific region, 5Europe – WHO European region, 6Americas – WHO region of the Americas
Table 1: Distribution of MV genotypes by WHO geographical region 1950s – 2004. Countries in which MV virus has been detected. No 
distinction has been made between endemic transmission or instances of MV importation. (data reflects publications available as of 
August 2005). Refer to Additional file 1 for details of endemic transmission and imported measles cases and for complete referencing 
of data. (Continued)Virology Journal 2005, 2:87 http://www.virologyj.com/content/2/1/87
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Genotype A has been detected in acute cases of measles in
South and North America, China, Japan, Eastern Europe,
Finland and the UK over the last 40 years. Since, it is diffi-
cult to distinguish wild-type viruses in genotype A from
vaccine strains, these reports must be interpreted with cau-
tion since some of the sequences may have been derived
from vaccine associated cases or been the result of labora-
tory contamination [22,26,27]. In the future, detection of
genotype A viruses in association with acute cases of mea-
sles will need to be thoroughly scrutinized and additional
sequence data will need to be obtained from both clinical
samples and corresponding viral isolates.
Genotype B2, previously considered inactive [12], has
recently been detected in South Africa and Angola [28].
Genotype B3 was first detected in 1993 in Gambia but has
subsequently been detected in cases from Cameroon,
Nigeria, Ghana, Burkina Faso, DR Congo and the Sudan.
This genotype is the endemic genotype of West and Cen-
tral Africa and has been imported into numerous coun-
tries including France, Germany and the USA.
Outbreaks involving genotype C1 have occurred in Can-
ada, Japan, Germany and most recently in the early 1990s
in Argentina, which was the last reported outbreak involv-
ing genotype C1 circulation. Genotype C2 has circulated
widely throughout the European continent and has been
exported to the USA and Canada from France, Italy and
Germany, where it was known to be an endemic genotype
until 2001. This genotype was also identified in Australia
from 1990 to 1991 and Morocco in 1998 & 1999. An
importation of genotype C2 to the USA was linked with
travel from Zimbabwe in 1998 although there are no
reports to indicate that this strain was circulating in South-
ern Africa during this time [6].
Characterization of archived MV isolates in Australia from
1971, suggest that genotype D1 may have been the
endemic strain in Australia during the pre-vaccine era.
Sequences from SSPE cases in Northern Ireland and the
UK indicate that genotype D1 was also detected in Britain
before the widespread use of vaccine. Genotype D1 has
not been detected since 1986 and is considered inactive.
Genotype D2 appears to have been the endemic strain of
Southern Africa from the late 1970s to 2000. This geno-
type was also responsible for the large outbreak in Ireland
in 1999 – 2000, which resulted in importations to both
the UK and USA. Genotype D3 is currently endemic in
Papua New Guinea and possibly the Philippines, given
that several measles cases in the USA have been linked
with travel from the Philippines. Additionally this geno-
type has been associated with a case of SSPE in South
Africa, and has been detected in Australia, USA and Can-
ada, the UK and Denmark, in most cases with epidemio-
logical links of importation from Japan or the Philippines.
Genotype D4 is widely distributed and has been associ-
ated with multiple outbreaks on the Indian sub-conti-
nent, East and South Africa and a large outbreak in
Quebec Province, Canada in 1989. Recently genotype D4
viruses, imported from the Indian sub-continent and East
and South Africa, have been epidemiologically linked
with cases in Canada, the USA, the UK, other European
countries and Australia. Genotypes D4 and D2 appear to
have been co-circulating in Southern Africa from the late
1970s to the late 1990s. Genotype D5 is endemic in Cam-
bodia and has been associated with measles cases detected
in the Americas, the UK, Germany and Australia. Epidemi-
ological investigations have identified Japan and Thailand
as the main sources for these importations. Until recently
both genotype D3, and genotype D5 were endemic in
Japan [26,29-31]. However, recent evidence suggests that
these genotypes may no longer be predominant in Japan
[32]. Genotype D6 has circulated widely throughout the
European continent and may have been the endemic gen-
otype of Europe, in conjunction with genotype C2, since
the 1990s. This genotype is endemic in Turkey [33] and
the Russian Federation [34]. Genotype D7 circulated in
the UK and Australia during the 1980s. Chains of trans-
mission of this genotype have been associated, through
epidemiological investigations, with Sweden and other
European countries, including Italy where it was identi-
fied in the large measles outbreak in 2002. Genotype D7
has been imported into the US from multiple European
sources from 2001 to 2003. Recently this genotype
replaced genotypes C2 and D6 as the most commonly iso-
lated genotype in Germany [35]. Genotype D8 appears to
be co-circulating with genotype D4 on the Indian sub-
continent and Ethiopia, although the first known descrip-
tion of this genotype was in the UK, from where it has
been regularly detected. However, investigations have
linked UK cases with importations of virus not only from
the Indian sub-continent but also from the Balkans and
Oman [36]. Genotype D8 has been imported into Aus-
tralia and the USA from India and Bangladesh. Genotype
D9, first described after importation to Australia from
Indonesia (Bali) in 1999, was isolated during the large
outbreak in 2000 – 2001 in Colombia and Venezuela. D9
was associated with an outbreak in Japan in 2004. Analy-
sis of wild-type viruses isolated in Uganda in 2000–2002
indicated the presence of a new genotype, which has been
proposed as genotype d10 [Genbank accession numbers
AY923185 through AY923212] [37].
A few genotype E viruses and related SSPE cases were
reported in the early 1970s. Genotype F sequences have
been identified on two occasions, both were SSPE cases
wherein acute measles infection was documented in 1967
and 1968. Thus both genotypes E and F probably circu-
lated in the pre-vaccine era [19,22].Virology Journal 2005, 2:87 http://www.virologyj.com/content/2/1/87
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Clade G, previously consisting of one genotype (G), has
recently been expanded to contain three genotypes. The
original genotype G (now G1) had not been detected
since 1983 and was thought to have been extinct. How-
ever, recent investigations have identified two new geno-
types (G2 & G3), both of which have been predominantly
associated with chains of transmission within and impor-
tation from Indonesia and Malaysia [38-40].
Clade H viruses originally consisted of a single genotype
but recently this clade has been expanded to contain two
genotypes (H1 & H2). Both genotypes are predominant in
the Asian and South East Asian regions. Genotype H1 has
mainly been associated with transmission within or
importations from China and was detected during the
large measles epidemic in Korea in 2000 – 2001 [41].
Genotype H1 may now be dominant in Japan [32,42].
The WHO Western Pacific Regional Reference Laboratory
for measles recently confirmed circulation of this geno-
type in Mongolia. Genotype H2, first described from sam-
ples recovered from China, has been more recently
associated with importations from Vietnam [43].
Some genotypes of MV are associated with a particular
geographical region, while other genotypes are more
widely distributed. In particular, clade B is predominant
in measles transmission in Sub Saharan and Central
Africa, clade G in South East Asia and clade H in South
East Asia and China. Clade D viruses, on the other hand,
appear to be more widely distributed and are endemic in
Eastern Africa, parts of Europe and the Indian sub-conti-
nent.
Determination of measles genotypes in countries that
have not yet conducted molecular surveillance can be
investigated, by proxy, from cases epidemiologically
linked to imported cases. For example, the Philippines
have not reported an endemic MV genotype but multiple
importations to the USA associated with travel to, or con-
tact with, the Philippines have resulted in the supposition
that genotype D3 is the predominant circulating genotype
in the Philippines [6,44]. However, caution must be taken
when identifying genotypes by proxy as the genotype
detected may not be the type that is endemic in the region.
In some cases, genotypes have been epidemiologically
linked to countries with no history of circulation of that
genotype. For example, genotype G2 has been reportedly
associated with importations to the UK from Mexico,
South Africa and Australia, none of which have reported
endemic circulation of genotype G2 [36]. In these cases
infection may have occurred while the patient was in tran-
sit or at venues frequented by other travellers and might
not reflect the circulating genotype.
Simultaneous circulation of multiple genotypes has been
reported in several regions. Genotypes D3 and D5 co-cir-
culated in Japan since the mid 1980s and the relative
number of isolations changed over time. During the late
1980s genotype D3 was detected more frequently, but by
1990 D5 was more common [42,45]. Genotypes D2 and
D4 appear to be co-circulating throughout Eastern and
Southern Africa. Genotypes C2 and D6 continue to be
detected in some parts of Europe and North Africa [35].
Rima et al described a shift from genotype C2 to genotype
D6 in Spain in the early 1990s [24]. Santibanez et al
recently demonstrated the shift from detection of mostly
genotypes C2 and D6 in Germany to detection of mostly
genotype D7 [46]. The shift of genotypes occurs in coun-
tries that have sub-optimal measles control programs,
resulting in interruption of endemic transmission for
short periods. However, failure to maintain high levels of
population immunity results in the accumulation of sus-
ceptible individuals and creates conditions that favour the
rapid transmission of a newly introduced genotype.
Therefore, the apparent genotype switching is most likely
due to changes in the distribution of susceptible individ-
uals in the region.
Nine new MV genotypes have been identified since 1990
reflecting increased surveillance of measles cases and tech-
nological advances, rather than recent evolution. The des-
ignation of new genotypes, such as the newly proposed
genotype d10, is likely to continue as the molecular anal-
ysis of viral isolates becomes routinely integrated into
more countries within the global WHO measles labora-
tory network and more sequence data are added to the
database. For example, genotype B3 may eventually be
reclassified as two separate genotypes since this genotype
contains viruses in two distinct clusters [47-49]. Charac-
terization of viruses imported into Australia has detected
three previously unrecognised genotypes (D7, D9 & G3)
due partly to the frequency of travel between South East
Asia and Australia and also to the comprehensive measles
surveillance conducted by Australian laboratories
[7,38,50].
The mutation rate amongst field isolates of MV is low and
appears to be random rather than driven by vaccine pres-
sure or immune responses [3,24,26]. Within a genotype,
nucleotide differences (virus lineage) can assist in distin-
guishing separate episodes of transmission [24,51,52]. In
countries or regions with endemic (ongoing and constant
MV transmission) measles, many lineages of a single gen-
otype may co-exist; however as countries begin to move
from endemic to epidemic measles (MV transmission
resulting in a higher number of cases than normally
expected, typically against a background of little or no MV
transmission)[53], the diversity of sequences within theVirology Journal 2005, 2:87 http://www.virologyj.com/content/2/1/87
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circulating genotypes decreases [43,54-57]. In fact, the
genotype D6 virus associated with a large measles out-
break that occurred in several South American countries
between 1996 and 1997 had identical N gene sequences
suggesting rapid spread of a single lineage [51]. Analysis
of measles viruses circulating in Burkina Faso, before and
after a mass vaccination campaign, showed that the
number of circulating lineages was greatly reduced follow-
ing the campaign. Sequence analysis of viruses isolated
from outbreaks that occurred after the vaccination cam-
paign suggested that virus was introduced from a single
source [57].
Many recent measles outbreaks have been reported with
no accompanying molecular genotyping investigations,
for instance in Afghanistan [58], Niger [59] and the Phil-
ippines [60]. These outbreaks highlight the need to extend
molecular surveillance capabilities to regions where mea-
sles remains endemic. Recent studies have described the
recovery of MV RNA by RT-PCR from oral fluid, dried
blood and dried oral fluid [61-63]. These samples, which
are easy to collect, prepare and transport by post to labo-
ratories capable of MV genotyping, have the potential to
extend molecular surveillance for measles virus to remote
settings and countries with limited infrastructure. How-
ever conventional samples such as nasopharyngeal swabs,
urine and peripheral blood lymphocytes should continue
to be collected, if logistically possible, because of the
higher sensitivity of these sample types for detecting MV
RNA.
Molecular surveillance undertaken in the early stages of
measles control can facilitate identification of endemic
genotypes. Over time or after intervention programs con-
tinued molecular surveillance, in conjunction with case
based epidemiological investigations, can detect the inter-
ruption of endemic transmission [1]. Additionally, molec-
ular analysis of specimens from cases facilitates both
linkage to, and separation from, contemporaneous cases
and clusters, assisting classical epidemiological investiga-
tions and the tracking of chains of transmission [7,64].
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
MAR initiated the review and drafted the preliminary
manuscript. JSR and PAR provided additional data and
contributed to manuscript revisions. All authors read and
approved the final manuscript.
Additional material
Acknowledgements
Thanks to Doris Chibo, Graham Tipples, David Brown, Li Jin for helpful 
suggestions and clarification of genotypes included in the table. Thanks to 
Doris Chibo and Heath Kelly for critical review of the earlier drafts of the 
manuscript. MAR received funding through a National Health and Medical 
Research Council Public Health PhD Research Scholarship. The authors 
welcome amendments, additions and updates to the comprehensive table 
submitted as Additional file 1. Regularly updated versions of the additional 
file will be available from the measles Global Specialized Laboratory at the 
Centers for Disease Control and Prevention, Atlanta Georgia, USA http://
www.cdc.gov/ncidod/dvrd/revb/measles/index.htm
References
1. Rota PA, Bellini WJ: Update on the global distribution of geno-
types of wild type measles viruses.  J Infect Dis 2003, 187 (Suppl
1):S270-276.
2. World Health Organization: Nomenclature for describing the
genetic characteristics of wild-type measles viruses (update).
Part I.  Wkly Epidemiol Rec 2001, 76:242-247.
3. Tamin A, Rota PA, Wang ZD, Heath JL, Anderson LJ, Bellini WJ:
Antigenic analysis of current wild type and vaccine strains of
measles virus.  J Infect Dis 1994, 170:795-801.
4. Klingele M, Hartter HK, Adu F, Ammerlaan W, Ikusika W, Muller CP:
Resistance of recent measles virus wild-type isolates to anti-
body-mediated neutralization by vaccinees with antibody.  J
Med Virol 2000, 62:91-98.
5. Mulders MN, Truong AT, Muller CP: Monitoring of measles elim-
ination using molecular epidemiology.  Vaccine 2001,
19:2245-2249.
6. Rota PA, Liffick SL, Rota JS, Katz RS, Redd S, Papania M, Bellini WJ:
Molecular epidemiology of measles viruses in the United
States, 1997-2001.  Emerg Infect Dis 2002, 8:902-908.
7. Chibo D, Riddell MA, Catton MG, Lyon M, Lum G, Birch CJ: Studies
of measles viruses circulating in Australia between 1999 and
2001 reveals a new genotype.  Virus Res 2003, 91:213-221.
8. Redd SC, Markowitz LE, Katz SL: Measles Vaccine.  In Vaccines 3rd
edition. Edited by: Plotkin SA and Orenstein WA. Philadelphia, Saun-
ders, W. B.; 1999:222 -2266. 
9. Jenkin GA, Chibo D, Kelly HA, Lynch PA, Catton MG: What is the
cause of a rash after measles-mumps-rubella vaccination?
Med J Aust 1999, 171:194-195.
Additional File 2
Sequence and alignment of World Health Organisation designated mea-
sles virus reference strains. Aligned sequence of the 456 nucleotides at the 
COOH terminus of the N protein for each measles virus reference strain 
as designated by the World Health Organisation. These sequences should 
be used in phylogenetic analysis to determine measles virus genotype of 
newly derived sequence.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1743-
422X-2-87-S2.doc]
Additional File 1
Table: Temporal and geographical distribution of measles of measles virus 
genotypes 1950 – 2004 (data reflects publications available as of August 
2005). Measles virus genotypes listed alphabetically, by year of circula-
tion, location and associated publication.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1743-
422X-2-87-S1.doc]Virology Journal 2005, 2:87 http://www.virologyj.com/content/2/1/87
Page 8 of 9
(page number not for citation purposes)
10. Rota PA, Khan AS, Durigon E, Yuran T, Villamarzo YS, Bellini WJ:
Detection of measles virus RNA in urine specimens from
vaccine recipients.  J Clin Microbiol 1995, 33:2485-2488.
11. World Health Organization: Expanded Programme on Immuni-
zation (EPI). Standardization of the nomenclature for
describing the genetic characteristics of wild-type measles
viruses.  Wkly Epidemiol Rec 1998, 73:265-269.
12. World Health Organization: Update of the nomenclature for
describing the genetic characteristics of wild- type measles
viruses: new genotypes and reference strains.  Wkly Epidemiol
Rec 2003, 78:229-232.
13. Medline/PubMed   [http://www.ncbi.nlm.nih.gov/entrez/
query.fcgi?db=PubMed]
14. Centers for Disease Control and Prevention: Global Laboratory
Network for Measles Surveillance : USA Genotyping Results
2000 - 2004.   [http://www.cdc.gov/ncidod/dvrd/revb/measles/
us_geno_rslt.htm].
15. Pan American Health Organization: Measles main page.   [http://
www.paho.org/english/AD/FCH/IM/Measles.htm].
16. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Wheeler DL:
GenBank: update.  Nucleic Acids Res 2004, 32:D23-6.
17. International Society for Infectious Diseases: ProMED mail.   [http:/
/www.promedmail.org].
18. Infectious Diseases Society of America: Immunization Newsbrief.
[http://www.infoinc.com/imnews2/imnews.html].
19. Rima BK, Earle JA, Yeo RP, Herlihy L, Baczko K, ter Meulen V, Cara-
bana J, Caballero M, Celma ML, Fernandez-Munoz R: Temporal and
geographical distribution of measles virus genotypes.  J Gen
Virol 1995, 76:1173-1180.
20. Rota JS, Bellini WJ, Rota PA: Measles.  In Molecular Epidemiology of
Infectious Diseases Edited by: Thompson RCA. London, Arnold;
2000:168-180. 
21. Rota PA, Bloom AE, Vanchiere JA, Bellini WJ: Evolution of the
nucleoprotein and matrix genes of wild-type strains of mea-
sles virus isolated from recent epidemics.  Virology 1994,
198:724-730.
22. Christensen LS, Scholler S, Schierup MH, Vestergaard BF, Mordhorst
CH: Sequence analysis of measles virus strains collected dur-
ing the pre- and early-vaccination era in Denmark reveals a
considerable diversity of ancient strains.  APMIS 2002,
110:113-122.
23. Jin L, Beard S, Hunjan R, Brown DW, Miller E: Characterization of
measles virus strains causing SSPE: a study of 11 cases.  J Neu-
rovirol 2002, 8:335-344.
24. Rima BK, Earle JA, Baczko K, ter Meulen V, Liebert UG, Carstens C,
Carabana J, Caballero M, Celma ML, Fernandez-Munoz R: Sequence
divergence of measles virus haemagglutinin during natural
evolution and adaptation to cell culture.  J Gen Virol 1997,
78:97-106.
25. Rima BK: Molecular biological basis of measles virus strain dif-
ferences.  In Measles and Poliomyelitis Vaccines, Immunization and Con-
trol Edited by: Kurstak E. Vienna, Springer-Verlag; 1993:149-160. 
26. Rota PA, Rota JS, Bellini WJ: Molecular epidemiology of measles
virus.  Semin Virol 1995, 6:379-386.
27. Bellini WJ, Rota PA: Genetic diversity of wild-type measles
viruses: implications for global measles elimination pro-
grams.  Emerg Infect Dis 1998, 4:29-35.
28. Smit SB, Hardie D, Tiemessen CT: Measles virus genotype B2 is
not inactive: evidence of continued circulation in Africa.  J
Med Virol 2005, 77(4):550-557.
29. Takahashi M, Nakayama T, Kashiwagi Y, Takami T, Sonoda S,
Yamanaka T, Ochiai H, Ihara T, Tajima T: Single genotype of mea-
sles virus is dominant whereas several genotypes of mumps
virus are co-circulating.  J Med Virol 2000, 62:278-285.
30. Nakayama T, Mori T, Yamaguchi S, Sonoda S, Asamura S, Yamashita
R, Takeuchi Y, Urano T: Detection of measles virus genome
directly from clinical samples by reverse transcriptase-
polymerase chain reaction and genetic variability.  Virus Res
1995, 35:1-16.
31. Katayama Y, Shibahara K, Kohama T, Homma M, Hotta H: Molecu-
lar epidemiology and changing distribution of genotypes of
measles virus field strains in Japan.  J Clin Microbiol 1997,
35:2651-2653.
32. Zhou J, Fujino M, Inou Y, Kumada A, Aoki Y, Iwata S, Nakayama T:
H1 genotype of measles virus was detected in outbreaks in
Japan after 2000.  J Med Virol 2003, 70:642-648.
33. Guris D, Bayazit Y, Ozdemirer U, Buyurgan V, Yalniz C, Toprak I,
Aycan S: Measles epidemiology and elimination strategies in
Turkey.  J Infect Dis 2003, 187 Suppl 1:S230-4.
34. Ignatyev G, Agafonov AP, Kameneva S, Atrasheuskaya A: Molecular
epidemiological study of measles in Western Siberia (Russia)
during 1995 - 2001: in XIIth International Congress of Virol-
ogy.  Volume Poster Abstract  143V- #V1302. IUMS Paris, France; 2002. 
35. Tischer A, Santibanez S, Siedler A, Heider A, Hengel H: Laboratory
investigations are indispensable to monitor the progress of
measles elimination--results of the German Measles Sentinel
1999-2003.  J Clin Virol 2004, 31:165-178.
36. Ramsay ME, Jin L, White J, Litton P, Cohen B, Brown D: The elimi-
nation of indigenous measles transmission in England and
Wales.  J Infect Dis 2003, 187 (Suppl 1):S198-207.
37. Muwonge A, Nanyunja M, Rota PA, Bwogi J, Lowe L, Liffick S, Bellini
WJ, Sylvester S: New genotype of measles virus detected in
Uganda.  Emerg Infect Dis 2005, 11(10):1522-1526.
38. Chibo D, Riddell M, Catton M, Birch C: Novel measles virus gen-
otype, East Timor and Australia.  Emerg Infect Dis 2002,
8:735-737.
39. de Swart RL, Wertheim-van Dillen PM, van Binnendijk RS, Muller CP,
Frenkel J, Osterhaus AD: Measles in a Dutch hospital intro-
duced by an immuno-compromised infant from Indonesia
infected with a new virus genotype.  Lancet 2000, 355:201-202.
40. Rota PA, Liffick S, Rosenthal S, Heriyanto B, Chua KB: Measles gen-
otype G2 in Indonesia and Malaysia.  Lancet 2000,
355:1557-1558.
41. Na BK, Lee JS, Shin GC, Mi Shin J, Lee JY, Chung JK, Ha DR, Lee JK,
Ma SH, Cho HW, Kang C, Kim WJ: Sequence analysis of hemag-
glutinin and nucleoprotein genes of measles viruses isolated
in Korea during the 2000 epidemic.  Virus Res 2001, 81:143-149.
42. Nakayama T, Zhou J, Fujino M: Current status of measles in
Japan.  J Infect Chemother 2003, 9:1-7.
43. Xu W, Tamin A, Rota JS, Zhang L, Bellini WJ, Rota PA: New genetic
group of measles virus isolated in the People's Republic of
China.  Virus Res 1998, 54:147-156.
44. Rota JS, Rota PA, Redd SB, Redd SC, Pattamadilok S, Bellini WJ:
Genetic analysis of measles viruses isolated in the United
States, 1995-1996.  J Infect Dis 1998, 177:204-208.
45. Kubo H, Iritani N, Seto Y: Co-circulation of two genotypes of
measles virus and mutual change of the prevailing genotypes
every few years in Osaka, Japan.  J Med Virol 2003, 69:273-278.
46. Santibanez S, Tischer A, Heider A, Siedler A, Hengel H: Rapid
replacement of endemic measles virus genotypes.  J Gen Virol
2002, 83:2699-2708.
47. Truong AT, Kreis S, Ammerlaan W, Hartter HK, Adu F, Omilabu SA,
Oyefolu AO, Berbers GA, Muller CP: Genotypic and antigenic
characterization of hemagglutinin proteins of African mea-
sles virus isolates.  Virus Res 1999, 62:89-95.
48. El Mubarak HS, van de Bildt MW, Mustafa OA, Vos HW, Mukhtar
MM, Ibrahim SA, Andeweg AC, El Hassan AM, Osterhaus AD, de
Swart RL: Genetic characterization of wild-type measles
viruses circulating in suburban Khartoum, 1997-2000.  J Gen
Virol 2002, 83:1437-1443.
49. Kouomou DW, Nerrienet E, Mfoupouendoun J, Tene G, Whittle H,
Wild TF: Measles virus strains circulating in Central and West
Africa: Geographical distribution of two B3 genotypes.  J Med
Virol 2002, 68:433-440.
50. Chibo D, Birch CJ, Rota PA, Catton MG: Molecular characteriza-
tion of measles viruses isolated in Victoria, Australia,
between 1973 and 1998.  J Gen Virol 2000, 81:2511-2518.
51. Oliveira MI, Rota PA, Curti SP, Figueiredo CA, Afonso AM, Theo-
baldo M, Souza LT, Liffick SL, Bellini WJ, Moraes JC, Stevien KE,
Durigon EL: Genetic homogeneity of measles viruses associ-
ated with a measles outbreak, Sao Paulo, Brazil, 1997.  Emerg
Infect Dis 2002, 8:808-813.
52. Taylor MJ, Godfrey E, Baczko K, ter Meulen V, Wild TF, Rima BK:
Identification of several different lineages of measles virus.  J
Gen Virol 1991, 72:83-88.
53. Last JM: A Dictionary of Epidemiology.  4th edition. New York,
Oxford University Press; 2001. 
54. Mbugua FM, Okoth FA, Gray M, Kamau T, Kalu A, Eggers R, Borus P,
Kombich J, Langat A, Maritim P, Lesiamon J, Tipples GA: Molecular
epidemiology of measles virus in Kenya.  J Med Virol 2003,
71:599-604.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Virology Journal 2005, 2:87 http://www.virologyj.com/content/2/1/87
Page 9 of 9
(page number not for citation purposes)
55. Horm SV, Dumas C, Svay S, Feldon K, Reynes JM: Genetic charac-
terization of wild-type measles viruses in Cambodia.  Virus Res
2003, 97:31-37.
56. Hanses F, Truong AT, Ammerlaan W, Ikusika O, Adu F, Oyefolu AO,
Omilabu SA, Muller CP: Molecular epidemiology of Nigerian
and Ghanaian measles virus isolates reveals a genotype cir-
culating widely in western and central Africa.  J Gen Virol 1999,
80:871-877.
57. Mulders MN, Nebie YK, Fack F, Kapitanyuk T, Sanou O, Valea DC,
Muyembe-Tamfum JJ, Ammerlaan W, Muller CP: Limited diversity
of measles field isolates after a national immunization day in
Burkina Faso: progress from endemic to epidemic transmis-
sion?  J Infect Dis 2003, 187:S277-82.
58. Ahmad K: Measles epidemic sweeps through Afghanistan.  Lan-
cet 2000, 355:1439.
59. BBC News online: Niger: About 700 measles cases reported in
capital Niamey.   [http://news.bbc.co.uk].
60. Deutsche Presse Agentur: Seven Children Die from Measles In
Southern Philippine Village.   [http://www.dpa.de].
61. Nigatu W, Jin L, Cohen BJ, Nokes DJ, Etana M, Cutts FT, Brown DW:
Measles virus strains circulating in Ethiopia in 1998-1999:
Molecular characterisation using oral fluid samples and iden-
tification of a new genotype.  J Med Virol 2001, 65:373-380.
62. De Swart RL, Nur Y, Abdallah A, Kruining H, El Mubarak HS, Ibrahim
SA, Van Den Hoogen B, Groen J, Osterhaus AD: Combination of
Reverse Transcriptase PCR Analysis and Immunoglobulin M
Detection on Filter Paper Blood Samples Allows Diagnostic
and Epidemiological Studies of Measles.  J Clin Microbiol 2001,
39:270-273.
63. Chibo D, Riddell MA, Catton MG, Birch CJ: Applicability of Oral
Fluid Collected onto Filter Paper for Detection and Genetic
Characterization of Measles Virus Strains.  J Clin Microbiol 2005,
43:3145-3149.
64. Rota JS, Heath JL, Rota PA, King GE, Celma ML, Carabana J, Fernan-
dez-Munoz R, Brown D, Jin L, Bellini WJ: Molecular epidemiology
of measles virus: identification of pathways of transmission
and implications for measles elimination.  J Infect Dis 1996,
173:32-37.